Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

Clinical trial NCT02676778 · COMPLETED

Trial details

NCT number: NCT02676778
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma Cutaneous T-cell Lymphoma

Start date: 2016-03-28
Primary completion: 2019-04-26
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.